Kinga Piorecka

Scopus Author ID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 6

Top Topics

Gas Chromatography

Early Breast Cancer

Top Venues

Materials (Basel, Switzerland)

Journal of medicinal chemistry

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Kinga Piorecka, Jan Kurjata, Bartłomiej Gostyński, Sławomir Kaźmierski, Wlodzimierz A Stanczyk, Monika Marcinkowska, Anna Janaszewska, Barbara Klajnert-Maculewicz
Is acriflavine an efficient co-drug in chemotherapy? RSC advances 13 (31) (2023)
Kinga Piorecka, Jan Kurjata, Wlodzimierz A Stanczyk
Acriflavine, an Acridine Derivative for Biomedical Application: Current State of the Art. Journal of medicinal chemistry 65 (17) (2022)
Kinga Piorecka, Jan Kurjata, Wlodzimierz A Stanczyk
Nanoarchitectonics: Complexes and Conjugates of Platinum Drugs with Silicon Containing Nanocarriers. An Overview. International journal of molecular sciences 22 (17) (2021)
Kinga Piorecka, Jan Kurjata, Irena I Bak-Sypien, Marek Cypryk, Urszula Steinke, Wlodzimierz A Stanczyk
Reasons for enhanced activity of doxorubicin on co-delivery with octa(3-aminopropyl)silsesquioxane. RSC advances 10 (26) (2020)
Kinga Piorecka, Anna Janaszewska, Marta Majkowska, Monika Marcinkowska, Jan Kurjata, Slawomir Kazmierski, Ewa Radzikowska-Cieciura, Bartlomiej Kost, Przemyslaw Sowinski, Barbara Klajnert-Maculewicz, Wlodzimierz A Stanczyk
Hydrophilic Polyhedral Oligomeric Silsesquioxane, POSS(OH)32, as a Complexing Nanocarrier for Doxorubicin and Daunorubicin. Materials (Basel, Switzerland) 13 (23) (2020)
Kinga Piorecka, Jan Kurjata, Wlodzimierz A Stanczyk
Novel Polyhedral Silsesquioxanes [POSS(OH)32] as Anthracycline Nanocarriers-Potential Anticancer Prodrugs. Molecules (Basel, Switzerland) 26 (1) (2020)